Description
NFX Bio is committed to backing Scientist-Founders who are inspired to change the world. But there are far fewer scientists-Founders today than there should be. Instead, scientists often follow the path that academia paves for them: from graduate school, to a PhD, to a postdoc, to another role in academia.
In this episode, NFX General Partner and Head of NFX Bio, Omri Amirav-Drory, sat down with Stanford professor and Pumpkinseed Founder Jennifer Dionne and former Columbia professor and Founder of Eleven Therapeutics Yaniv Erlich to discuss forging your own path: starting your own company.
Here’s how to think through leaving academia, how to know whether it’s time to spin out of your university, and the key takeaways from each of their scientist-turned-founder journeys.
Read the full essay here - https://www.nfx.com/post/techbio-scientists-academia-or-startup
This is an essay readout using an AI voice clone of NFX general partner, Morgan Beller. Morgan navigates the world of stablecoins and defense tech, emphasizing the need for a synergy between regulators and stablecoin creators. She dives into the historical significance of the dollar's power and...
Published 05/30/24
In this episode, Omri Amirav-Drory (NFX), Joe Betts-LaCroix (Retro Bio), and Alex Colville (Age1) discuss the history, recent progress, and hurdles in the longevity industry, including the evaluation of potential founders and business risks. The discussion further encompasses the global...
Published 04/10/24